Stay updated with breaking news from Potential Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Organicell And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients PRESS RELEASE Miami, FL Miami -Organicell Regenerative Medicine, Inc. , a... | February 8, 2022
MIAMI, FL / ACCESSWIRE / December 29, 2021 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, is pleased
Some nutritional supplements may help prevent or mitigate COVID-19 severity With hundreds of thousands of new cases being reported every day, over a year after its onset, the coronavirus disease 2019 (COVID-19) pandemic is still making its presence felt worldwide. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic is estimated to be about ten-fold bigger than the number of reported infections. It has proved difficult to contain the spread of SARS-CoV-2 because of the asymptomatic nature of a large percentage of infections, the high transmissibility of the...
(1) DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension (XR-NTX) administered once every three weeks plus oral extended-release bupropion administered daily as a combination treatment for adults with moderate or severe methamphetamine use disorder (MUD) were published today by Dr. Madhukar H. Trivedi et al. in the New England Journal of Medicine (NEJM). 1 This is the second published study evaluating this combination regimen for the treatment of MU...